Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Total 13F shares
-
1,032,562
-
Share change
-
+1,032,562
-
Total reported value
-
$3,003,000
-
Price per share
-
$2.91
-
Number of holders
-
7
-
Value change
-
+$3,003,000
-
Number of buys
-
7
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q4 2018
As of 31 Dec 2018 DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) had 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,032,562 shares of stock of the company.
Largest 7 holders included WEXFORD CAPITAL LP, G2 Investment Partners Management LLC, Manatuck Hill Partners, LLC, Worth Venture Partners, LLC, BANK OF AMERICA CORP /DE/, UBS Group AG, and ROYAL BANK OF CANADA.
This table shows 7 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.